Structure Therapeutics American Stock Analysis

Structure Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Structure Therapeutics recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. To learn more about Structure Therapeutics American call Raymond Stevens at (650) 457-1978 or check out https://structuretx.com.

Structure Therapeutics Investment Alerts

Structure Therapeutics Upcoming and Recent Events

Structure Largest EPS Surprises

View All Earnings Estimates

Structure Therapeutics Environmental, Social, and Governance (ESG) Scores

Structure Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.72 B.

Structure Profitablity

Management Efficiency

Structure Therapeutics has return on total asset (ROA) of (0.1301) % which means that it has lost $0.1301 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1769) %, meaning that it created substantial loss on money invested by shareholders. Structure Therapeutics' management efficiency ratios could be used to measure how well Structure Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.24. At this time, Structure Therapeutics' Total Assets are relatively stable compared to the past year. As of 11/22/2024, Non Current Assets Total is likely to grow to about 8.8 M, while Non Currrent Assets Other are likely to drop slightly above 42.8 K.

Technical Drivers

As of the 22nd of November, Structure Therapeutics has the Coefficient Of Variation of (1,161), risk adjusted performance of (0.06), and Variance of 15.63. Structure Therapeutics technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Structure Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Structure Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 33.41 per share. Given that Structure Therapeutics has information ratio of (0.11), we advise you to double-check Structure Therapeutics American's current market performance to make sure the company can sustain itself at a future point.

Structure Therapeutics Price Movement Analysis

Structure Therapeutics Insider Trading Activities

Structure Therapeutics Predictive Daily Indicators

Structure Therapeutics Corporate Filings

Structure Therapeutics Forecast Models

Structure Therapeutics' time-series forecasting models are one of many Structure Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Structure Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Structure Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Structure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Structure Therapeutics. By using and applying Structure Stock analysis, traders can create a robust methodology for identifying Structure entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Structure analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Structure analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Structure Therapeutics American stock analysis indicators help investors evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Structure Therapeutics shares will generate the highest return on investment. By understating and applying Structure Therapeutics stock analysis, traders can identify Structure Therapeutics position entry and exit signals to maximize returns.

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.